ACH 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

03
价格 $0.51
52周区间 $1–$6

ACH 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

04
区间
条形图

柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。

股票拆分 7
除息日 拆股 类型
2010年4月1日 3-for-2 正向
1994年6月9日 3-for-2 正向
1993年3月23日 3-for-2 正向
1991年7月17日 3-for-2 正向
1988年6月1日 3-for-2 正向
1985年9月3日 3-for-2 正向
1982年11月1日 2-for-1 正向

关于 Accendra Health, Inc. Common Stock 公司概况(来自维基百科)

05 · wikidata

Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019.

History

Owens & Minor originally opened as a pharmacy company in downtown Richmond, Virginia in 1882, inside a historic building which still stands today. The company continued this business for over half a century until, in 1954, Gil Minor, Jr. bought out Bodeker Drug Company, a smaller operation in the same industry, changing the company name to Owens, Minor & Bodeker.

In 1966, the company acquired Virginia A&J Hospital Supply, adding medical and surgical distribution to its portfolio. By 1970, OMB had opened Cardinal Drug Centers, merchandising its products to independent drug companies, stocking shops with over 25,000 items within two years. Around this time, disposable items were distributed to hospitals for various medical procedures. G. Gilmer Minor III, a direct relation to the founder, became CEO in 1984. By 1988, Owens & Minor began trading on the New York Stock Exchange under the ticker OMI. It was around this time that revenues earned the company a Fortune 500 ranking.

By 1999, the company had refocused toward medical supply chain management. Throughout the 2000s, Owens & Minor acquired various medical distributors across the United States, notably the hospital distributor McKesson Medical-Surgical Inc., a business unit of McKesson, for $152.1 million, on September 30, 2006. In 2012, it entered the European market, opening offices in Spain, France, Germany, Poland, and the Czech Republic after the acquisition of Movianto Group. In 2014, the corporation acquired ArcRoyal, a privately held medical kit company based in Dublin, Ireland.

In 2018, it acquired Halyard Health’s Surgical & Infection Prevention business for $710 million, the largest acquisition in the company’s history. Halyard is a manufacturer of sterilization wrap, facial protection products, exam gloves, protective apparel, surgical drapes and surgical gowns.

In May 2022, Owens & Minor stated that 45 percent of the items it offers are in some way supply-constrained due to the 2021–2022 global supply chain crisis. The following month, the company broke ground in Morgantown, West Virginia for a 350,000 square-foot medical supplies and logistics center, to be completed in late 2023, which will include dedicated acute care medical distribution facilities and clinical supply capabilities.

In July 2024, the company announced it had agreed to acquire medical equipment firm Rotech Healthcare for $1.36 billion. However, the companies terminated the deal in June 2025, citing regulatory hurtles. As a result, the Owens & Minor paid Rotech an $80 million termination payment.

Personnel

On March 7, 2019 Edward A. Pesicka became president and CEO, then also joined the company's Board of Directors. Pesicka was a former executive at Thermo Fisher Scientific.

Richmond, Virginia center

In the fourth quarter of 2017, Owens & Minor opened a second office and customer service center in downtown Richmond, Virginia as part of a business rebranding strategy. The corporation also continued to work from its various offices across the United States.

Movianto

In 2018, the company’s Movianto subsidiary won a contract estimated at £10.5m a year to warehouse and distribute the UK government’s stock of emergency personal protection equipment (PPE) which had previously been managed by DHL.

Following a dispute over payment of rent, Movianto gained a UK High Court injunction in March 2019 to stop Industrial North West LLP, owner of the rented industrial property, from locking the gates and thereby preventing the company from conducting its business.

In 2020, Movianto was criticised as causing delays to the distribution of the UK government’s stockpile of PPE. Following news of shortages in hospitals, the British army was sent to Movianto’s warehouse to assist in the rapid deployment of PPE, with the Department of Health and Social Care contradicting the allegation. An investigation did establish, however, that Movianto had previously stored the equipment in a smoke-damaged warehouse that was found to contain asbestos.

On January 16, 2020, Owens & Minor announced its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company providing healthcare logistics services to European markets, with the sale completed June 18, 2020.

Divest of P&HS - Rebrand Accendra Health, Inc.

On December 31 2025, Owens & Minor, Inc. announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.

来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗

Wikidata ↗

行业板块Health Care 行业Health Care 员工6500 国家US

10年表现 收入、净利润、利润率和每股收益趋势

06
收入·
2015-12-31 → 2022-12-31
EPS·
2019-12-31 → 2022-12-31
自由现金流·
2019-12-31 → 2022-12-31
净利率·
2019-12-31 → 2022-12-31
估值与比率 07–12

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

此比率组尚无数据

基本面数据不足,尚无法计算此比率组。

价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判

股息 收益率、派息率、股息历史、5年CAGR

13
年度化派息≈$0.01每季度支付
除息日金额货币收益率
十二月 14, 2021$0.00USD≈0.03%
九月 14, 2021$0.00USD≈0.03%
六月 14, 2021$0.00USD≈0.03%
三月 12, 2021$0.00USD≈0.03%
十二月 14, 2020$0.00USD≈0.04%
九月 14, 2020$0.00USD≈0.08%
六月 12, 2020$0.00USD≈0.16%
三月 13, 2020$0.00USD≈0.28%
十二月 13, 2019$0.00USD≈1.6%
九月 13, 2019$0.00USD≈5.5%
六月 13, 2019$0.00USD≈20.8%
三月 14, 2019$0.00USD≈12.6%
十二月 14, 2018$0.08USD≈13.2%
九月 14, 2018$0.26USD≈6.4%
六月 14, 2018$0.26USD≈6.4%
三月 14, 2018$0.26USD≈6.2%
十二月 14, 2017$0.26USD≈5.5%
九月 14, 2017$0.26USD≈3.6%
六月 13, 2017$0.26USD≈3.2%
三月 13, 2017$0.26USD≈2.9%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

14
平均惊喜 -6.8%
下次报告 十月 28, 2026
期间报告EPS ActualEPS 预期惊喜
2026年6月30日 八月 10, 2026 $-0.19 $-0.09 -113.0%
2026年3月31日 $-0.04 $-0.10 60.9%
2025年12月31日 $0.21 $0.22 -5.8%
2025年9月30日 $0.25 $0.23 6.7%
2025年6月30日 $0.26 $0.28 -6.3%
2025年3月31日 $0.23 $0.20 16.6%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

15
损益表 16
指标 趋势 2022202120202019201820172016
Revenue $290.99B$298.89B$203.99B$190.22B$180.35B$181.02B$144.85B
Cost of Revenue $259.70B$264.17B$188.52B$179.28B$167.11B$166.29B$133.70B
Gross Profit $31.28B$34.72B$15.47B$10.93B$13.24B$14.73B$11.15B
R&D Expense $4.81B$2.42B$1.47B$941M$627M$498M$169M
SG&A Expense $6.01B$6.33B$5.06B$3.97B$3.98B$4.55B·
Operating Income $16.39B$18.67B$7.60B$6.21B$6.82B··
Interest Expense $3.83B$4.51B$4.99B$4.38B$4.69B$4.83B$4.76B
Interest Income $477M$311M$266M$261M$492M$707M$816M
Pretax Income $13.21B$14.19B$2.89B$1.87B$2.27B$3.05B$1.62B
Income Tax $2.37B$2.87B$641M$632M$826M$644M$404M
Net Income $4.19B$5.76B$862M$596M$709M$1.41B$366M
EPS (Basic) $0.24$0.33$0.03$0.02$0.03$0.09$0.02
EPS (Diluted) $0.24$0.33$0.03$0.02···
Shares (Basic) 17,022,67317,022,67317,022,67317,022,67316,842,71414,903,798,23614,903,798,236
Shares (Diluted) ···17,022,672,95116,842,713,73814,903,798,23614,903,798,236
EBITDA $16.39B$13.41B$6.02B····
资产负债表 11
指标 趋势 2022202120202019201820172016
Cash & Equivalents $16.82B$19.68B$9.67B$7.78B$19.13B$27.85B$23.85B
Receivables $5.87B$7.11B$9.31B$7.42B$8.10B··
Inventory $24.71B$21.64B$19.86B$19.52B$20.46B$20.55B$17.93B
Current Assets $54.54B$54.11B$46.27B$48.70B$58.90B$68.64B$66.49B
PP&E (Net) $109.28B$121.38B$130.93B$103.49B$99.61B$95.73B$90.37B
Goodwill $3.50B$3.51B$3.51B····
Total Assets $212.35B$224.86B$195.04B$203.14B$200.96B$199.82B$190.51B
Current Liabilities $62.37B$61.92B$62.63B$69.20B$74.84B$90.34B$83.18B
Total Liabilities $124.59B$135.17B$123.74B$132.38B$133.30B$134.07B$134.72B
Retained Earnings $10.09B$6.81B$-1.98B$-2.21B$-2.86B$-3.33B$-4.64B
Stockholders' Equity $54.40B$60.48B$54.45B$54.67B$52.42B$39.69B$38.17B
现金流 8
指标 趋势 2022202120202019201820172016
D&A ····$8.06B$7.06B$7.00B
Operating Cash Flow $27.75B$35.16B$19.42B$12.51B$13.02B$13.21B$11.61B
CapEx $4.42B$3.19B$10.33B$9.05B$6.75B$8.89B$6.33B
Investing Cash Flow $-3.42B$-1.67B$-3.31B$-13.40B$-5.53B$-5.60B$-2.63B
Dividends Paid $2.51B$579M$423M$223M$328M$309M$20M
Financing Cash Flow $-27.04B$-23.41B$-18.23B$-10.47B$-16.28B$-3.39B$-6.11B
Free Cash Flow $23.33B$26.19B$9.84B$3.58B···
Levered FCF $20.19B$23.50B$7.02B$501M···
盈利能力 8
指标 趋势 2022202120202019201820172016
Gross Margin 10.8%9.8%7.2%6.4%···
Operating Margin 5.6%5.0%3.2%····
Net Margin 1.4%1.9%0.40%0.45%···
Pretax Margin 4.5%3.8%1.2%1.1%···
EBITDA Margin 5.6%5.0%3.2%····
ROA 1.9%2.6%0.37%0.42%···
ROE 7.3%9.1%1.4%1.6%···
ROIC 24.7%17.9%8.1%····
流动性与偿付能力 3
指标 趋势 2022202120202019201820172016
Current Ratio 0.90.90.70.7···
Quick Ratio 0.40.50.30.2···
Interest Coverage 4.33.81.6····
效率 3
指标 趋势 2022202120202019201820172016
Asset Turnover 1.31.40.90.9···
Inventory Turnover 11.212.68.88.9···
Receivables Turnover 44.833.322.324.5···
每股 3
指标 趋势 2022202120202019201820172016
Revenue / Share ···$11.17···
Cash Flow / Share ···$0.73···
EPS (TTM) $0.24$0.29$0.03$0.02···
估值 (TTM) 6
指标 趋势 2022202120202019201820172016
Revenue TTM $290.99B$269.75B$185.99B$190.22B···
Net Income TTM $4.19B$5.08B$764M$596M···
P/E 81.7152.1901.7235.0···
Earnings Yield 1.2%0.66%0.11%0.43%···
Payout Ratio 60.0%9.1%48.1%26.2%···
Annual Payout $2.51B$461M$356M$223M···

最近期在左侧 · 空值显示为 ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

16
指标 2022-12-312021-12-312020-12-312019-12-312018-12-31
收入 $290.99B $298.89B $203.99B $190.22B $180.35B
毛利率 % 10.8% 9.8% 7.2% 6.4% ·
营业利润率 % 5.6% 5.0% 3.2% · ·
净收入 $4.19B $5.76B $862M $596M $709M
稀释后每股收益 (EPS) $0.24 $0.33 $0.03 $0.02 ·

机构持有人 (13F) 161 家申报者 · $236.6M 总计 · 截至 2026年6月30日

17

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

持有人 161
持有价值 $236.6M
新仓位 22
已退出持仓 21
机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
22 (-7 与上一季度对比) 21 (-25 与上一季度对比) 47 (+8 与上一季度对比) 45 (-7 与上一季度对比) -61K

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
Coliseum Capital Management, LLC $44804760 13100807 18.94% 股份
BlackRock, Inc. $18824028 5504102 7.96% 股份
VANGUARD GROUP INC $17691199 6318285 7.48% 股份
BANK OF AMERICA CORP /DE/ $12912296 3775525 5.46% 股份
VANGUARD CAPITAL MANAGEMENT LLC $10560724 3087931 4.46% 股份
D. E. Shaw & Co., Inc. $10538412 3081407 4.45% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $9877158 2888058 4.17% 股份
Invenomic Capital Management LP $9618661 2812474 4.07% 股份
MARSHALL WACE, LLP $8832423 2582579 3.73% 股份
PARADIGM CAPITAL MANAGEMENT INC/NY $8675511 2536699 3.67% 股份
VANGUARD PORTFOLIO MANAGEMENT LLC $6945870 2030956 2.94% 股份
Dana Investment Advisors, Inc. $6650556 1944607 2.81% 股份
GEODE CAPITAL MANAGEMENT, LLC $6408062 1873127 2.71% 股份
DIMENSIONAL FUND ADVISORS LP $5609358 1640163 2.37% 股份
STATE STREET CORP $5475974 1601162 2.31% 股份
Connor, Clark & Lunn Investment Management Ltd. $4407652 1288787 1.86% 股份
AQR CAPITAL MANAGEMENT LLC $3650249 1067324 1.54% 股份
GOLDMAN SACHS GROUP INC $2923176 854730 1.24% 股份
TWO SIGMA INVESTMENTS, LP $2457441 718550 1.04% 股份
NORTHERN TRUST CORP $1989770 581804 0.84% 股份
WOLVERINE ASSET MANAGEMENT LLC $1942847 568084 0.82% 股份
TUDOR INVESTMENT CORP ET AL $1939995 567250 0.82% 股份
JANE STREET GROUP, LLC $1833462 536100 0.77% 买入期权
Vanguard Global Advisers, LLC $1742463 509492 0.74% 股份
VANGUARD FIDUCIARY TRUST CO $1665913 487109 0.70% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1575252 460600 0.67% 买入期权
TWO SIGMA ADVISERS, LP $1518922 542472 0.64% 股份
BW Gestao de Investimentos Ltda. $1446971 423091 0.61% 股份
CITADEL ADVISORS LLC $1321919 386526 0.56% 股份
CITADEL ADVISORS LLC $1191528 348400 0.50% 买入期权
Nebula Research & Development LLC $1115105 122539 0.47% 股份
RENAISSANCE TECHNOLOGIES LLC $1109492 324413 0.47% 股份
MORGAN STANLEY $1052342 307701 0.44% 股份
Linden Thomas Advisory Services, LLC $932501 272661 0.39% 股份
Bank of New York Mellon Corp $917257 268204 0.39% 股份
Nuveen, LLC $803515 234946 0.34% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $794692 232366 0.34% 股份
Kennondale Capital Management LLC $772544 225890 0.33% 股份
STRS OHIO $716148 209400 0.30% 股份
MILLENNIUM MANAGEMENT LLC $690902 202018 0.29% 股份
Cubist Systematic Strategies, LLC $593424 123630 0.25% 股份
BNP PARIBAS FINANCIAL MARKETS $546095 159677 0.23% 股份
WELLS FARGO & COMPANY/MN $542754 158700 0.23% 股份
XTX Topco Ltd $503725 147288 0.21% 股份
ARISTEIA CAPITAL, L.L.C. $447391 130816 0.19% 股份
Invesco Ltd. $446351 130512 0.19% 股份
Man Group plc $436009 127488 0.18% 股份
RAYMOND JAMES FINANCIAL INC $408047 119312 0.17% 股份
BRIDGEWAY CAPITAL MANAGEMENT, LLC $362520 106000 0.15% 股份
Allspring Global Investments Holdings, LLC $356879 99687 0.15% 股份

显示全部 161 个机构持有人 →

ETF持仓 由 18 只交易所交易基金持有

20

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
VFVA · VANGUARD WELLINGTON FUND 0.17% 426785 SH 2026年8月19日 每日
QIDX · Spinnaker ETF Series 0.11% 14310 NS 2026年7月31日 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0.02% 62833 SH 2026年8月19日 每日
IWC · iShares Trust 0.02% 248081 SH 2026年9月11日 每日
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 414904 SH 2026年8月19日 每日
DFSV · Dimensional ETF Trust 0.01% 233042 NS 2026年7月31日 N-PORT
RSSL · Global X Funds 0.01% 34414 NS 2026年7月31日 N-PORT
DFAT · Dimensional ETF Trust 0.00% 134690 NS 2026年7月31日 N-PORT
IWM · iShares Trust 0.00% 1902936 SH 2026年9月11日 每日
PRF · Invesco Exchange-Traded Fund Trust 0.00% 96796 SH 2026年10月1日 每日
DFAS · Dimensional ETF Trust 0.00% 29296 NS 2026年7月31日 N-PORT
ITOT · iShares Trust 0.00% 105616 SH 2026年9月8日 每日
IWV · iShares Trust 0.00% 19827 SH 2026年9月3日 每日
VXF · VANGUARD INDEX FUNDS 0.00% 833270 SH 2026年8月19日 每日
VTI · VANGUARD INDEX FUNDS 0.00% 2185973 SH 2026年8月19日 每日
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 6453 SH 2026年8月19日 每日
VHT · VANGUARD WORLD FUND 0.00% 184892 SH 2026年8月19日 每日
IWN · iShares Trust · 666394 SH 2026年9月11日 每日

ACH 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

21
评级 · 13 位分析师 卖出
中位数目标 $1.50 +196.9%
0 0.0% 强烈买入
0 0.0% 买入
6 46.2% 持有
6 46.2% 卖出
1 7.7% 强烈卖出

12个月价格目标

4 位分析师 · 2026-09-30

平均目标 $1.51 +199.4%

← 低于所有目标 当前价格 $0.51
最低$1.30 平均值$1.51 最高$1.75

同行比较(GICS 子行业) 关键指标与行业同行对比

22

财年依据,价格截至各公司上一个财年末收盘价。

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
ACH · · · · · ·
HSIC $8.81B 23.3 4.0% 3.0% 12.0% 31.1%
AHCO $1.35B -19.2 -0.49% -2.2% -4.6% ·
MEDS · · · · · ·
ZSTK $7M -0.1 -0.53% -335.6% -319.0% 4.6%
MCK $242.30B 22.5 12.4% 1.2% -224.3% 3.6%

我的指标 您的个人关注列表 — 来自完整基本面的选定行

26

选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。

您的选择已保存,并会跟随您浏览所有股票。

来源:SEC 20-F/A 于 一月 24, 2024 申报